[Subependymal giant cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients]
- PMID: 20643042
[Subependymal giant cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients]
Abstract
Objective: Presentation of 8 patients with subependymal giant-cell astrocytomas (SGCA) associated with tuberous sclerosis complex (TSC).
Material and methods: There are 8 patients, 6 males and 2 females with TSC, who presented with the tumour between the neonatal period and 24 years.
Results: All patients showed bilateral hypersignalised areas in zones close to the foramen of Monro. Three of the patients were admitted urgently due to blindness and increased intracranial pressure. Incomplete removal of the tumour has always been bad solution as it resulted in the death of the patient (in one case) or further surgery operation in the short term. Only one patient developed the tumour suddenly from pre-existing subependymal nodules from the childhood and they had to be removed at 24 years of age. By contrast, 32 patients with TSC and images of subependymal nodules whose CT or MR progress was followed up for between 10 and 30 years did not develop a tumour. One patient had to be operated four times over 20 years.
Conclusions: SGCA associated with TSC is a severe complication which as likely to develop and careful monitoring is required from neonatal age with periodicclinical and imaging studies in order to avoid its irreversible complications. Hydrocephaly, blindness and even the death can be the main consequences. Reintervention of the recurrent tumour is often necessary.
Similar articles
-
Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.Pediatr Neurol. 2014 Apr;50(4):307-12. doi: 10.1016/j.pediatrneurol.2013.12.004. Epub 2013 Dec 10. Pediatr Neurol. 2014. PMID: 24507694
-
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex.Ann Neurol. 2006 Mar;59(3):490-8. doi: 10.1002/ana.20784. Ann Neurol. 2006. PMID: 16453317
-
Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study.Neurosurgery. 1991 Jun;28(6):864-8. Neurosurgery. 1991. PMID: 2067610
-
Neonatal subependymal giant cell astrocytoma: new case and review of literature.Pediatr Neurol. 2007 Feb;36(2):128-31. doi: 10.1016/j.pediatrneurol.2006.08.009. Pediatr Neurol. 2007. PMID: 17275668 Review.
-
Hemorrhagic subependymal giant cell astrocytoma in a patient with tuberous sclerosis: case report and review of the literature.Neurol India. 2011 Nov-Dec;59(6):933-5. doi: 10.4103/0028-3886.91394. Neurol India. 2011. PMID: 22234227 Review. No abstract available.
Cited by
-
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective.Childs Nerv Syst. 2011 Aug;27(8):1203-10. doi: 10.1007/s00381-011-1406-0. Epub 2011 Feb 9. Childs Nerv Syst. 2011. PMID: 21305305 Review.
-
Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex.Childs Nerv Syst. 2014 Dec;30(12):2037-42. doi: 10.1007/s00381-014-2555-8. Epub 2014 Sep 17. Childs Nerv Syst. 2014. PMID: 25227171 Free PMC article.
-
Neurosurgical treatment of tuberous sclerosis complex lesions.Childs Nerv Syst. 2011 Aug;27(8):1211-9. doi: 10.1007/s00381-011-1488-8. Epub 2011 May 24. Childs Nerv Syst. 2011. PMID: 21607641 Review.
-
Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.Childs Nerv Syst. 2020 May;36(5):951-960. doi: 10.1007/s00381-019-04449-w. Epub 2019 Dec 18. Childs Nerv Syst. 2020. PMID: 31853898
-
Subependymal Giant Cell Astrocytoma Apoplexy: A Case Report and Systematic Review.Cureus. 2023 Feb 8;15(2):e34784. doi: 10.7759/cureus.34784. eCollection 2023 Feb. Cureus. 2023. PMID: 36915840 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials